Company performance
Add to research
Current Price
as of May 20, 2025$20.44
P/E Ratio
24.22
Market Cap
$4.88B
Description
Add to research
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
Metrics
Add to research
Overview
- HQRamsey, NJ
- SectorHealth Technology
- IndustryBiotechnology
- TickerADMA
- Price$20.44+1.24%
Trading Information
- Market cap$4.88B
- Float96.51%
- Average Daily Volume (1m)4,009,646
- Average Daily Volume (3m)3,698,024
- EPS$0.88
Company
- Revenue$459.38M
- Rev growth (1yr)40.22%
- Net income$26.90M
- Gross margin53.20%
- EBITDA margin32.10%
- EBITDA$36.85M
- EV$4.86B
- EV/Revenue10.59
- P/E24.22
- P/S10.89
- P/B13.06
- Debt/Equity21.96
Documents
Add to research
SEC Filings
Factset Street Account